Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
BeBetter Med Inc
BeBetter Med Inc
Fox Chase Cancer Center
Ruijin Hospital
Guangzhou Institute of Respiratory Disease
Huabo Biopharm Co., Ltd.
Emory University
Massachusetts General Hospital
Tianjin Medical University Cancer Institute and Hospital
Henan Cancer Hospital
GOG Foundation
SuZhou Stainwei Biotech Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Southern Europe New Drug Organization
National Cancer Institute (NCI)